Objective: To assess alterations in endothelial barrier integrity and poten
tial factors involved in zymosan-associated endothelial injury.
Design: Experimental study.
Setting: University hospital, Sweden.
Animals: 42 adult male Sprague-Dawley rats.
Interventions: One hour before an intraperitoneal injection of paraffin or
zymosan (0.25 mg/g body weight), 1.0 ml of a solution of saline, N-acetyl-L
-cysteine, dimethyl sulphoxide, indomethacin, verapamil, or allopurinol was
given intravenously.
Main outcome measures: Measurement of tissue water content, tissue intravas
cular plasma volume, interstitial fluid volume, and extravascular I-125-lab
elled human serum albumin distribution as well as plasma concentrations of
albumin, alpha(1)-macroglobulin, alpha(2)-antiplasmin, and antithrombin III
, 24 hours after the intraperitoneal injection.
Results: Endothelial permeability significantly increased in abdominal orga
ns and the gastrointestinal tract, and plasma antiplasmin concentrations de
creased. Pretreatment with N-acetyl-L-cysteine, dimethyl sulphoxide, or ind
omethacin protected against zymosan-induced endothelial barrier injury and
the decline in protease inhibitors in plasma to varying degrees, while pret
reatment with verapamil or allopurinol had a limited effect.
Conclusion: Oxygen free radicals, prostaglandin, and proteases may have rol
es in the pathogenesis of zymosan-induced endothelial barrier injuries, imp
lying that several mediators probably are interacting.